Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
The severely debilitating disease Congenital Muscular Dystrophy Type 1A (MDC1A) is caused by mutations in the gene encoding laminin-alpha2. Bax-mediated muscle cell death is a significant contributor to the severe neuromuscular pathology seen in the Lama2-null mouse model of MDC1A. To extend our understanding of pathogenesis due to laminin-alpha2-deficiency, we have now analyzed molecular mechanisms of Bax regulation in normal and laminin-alpha2-deficient muscles and cells, including myogenic cells obtained from patients with a clinical diagnosis of MDC1A. In mouse myogenic cells, we found that, as in non-muscle cells, Bax co-immunoprecipitated with the multifunctional protein Ku70. In addition, cell permeable pentapeptides designed from Ku70, termed Bax-inhibiting peptides (BIPs), inhibited staurosporine-induced Bax translocation and cell death in mouse myogenic cells. We also found that acetylation of Ku70, which can inhibit binding to Bax and can be an indicator of increased susceptibility to cell death, was more abundant in Lama2-null than in normal mouse muscles. Furthermore, myotubes formed in culture from human laminin-alpha2-deficient patient myoblasts produced high levels of activated caspase-3 when grown on poly-L-lysine, but not when grown on a laminin-alpha2-containing substrate or when treated with BIPs. Finally, cytoplasmic Ku70 in human laminin-alpha2-deficient myotubes was both reduced in amount and more highly acetylated than in normal myotubes. Increased susceptibility to cell death thus appears to be an intrinsic property of human laminin-alpha2-deficient myotubes. These results identify Ku70 as a regulator of Bax-mediated pathogenesis and a therapeutic target in laminin-alpha2-deficiency.
Vishnudas
Vivek K
VK
Neuromuscular Biology & Disease Group, Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02478, USA.
Miller
Jeffrey Boone
JB
D000107:Acetylation; D000328:Adult; D000818:Animals; D034961:Antigens, Nuclear / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007223:Infant; D000072200:Ku Autoantigen; D034904:Lamin Type A / Q000172:deficiency* / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018485:Muscle Fibers, Skeletal / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism* / Q000473:pathology; D009136:Muscular Dystrophies / Q000151:congenital / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D011485:Protein Binding; D055815:Young Adult; D051028:bcl-2-Associated X Protein / Q000235:genetics / Q000378:metabolism*
D034961:Antigens, Nuclear; D004268:DNA-Binding Proteins; D034904:Lamin Type A; D051028:bcl-2-Associated X Protein; C000606509:Xrcc6 protein, human; C000606510:Xrcc6 protein, mouse; D000072200:Ku Autoantigen
Development. 1993 Mar;117(3):1125-33
8391976
Mol Cell Biol. 2007 May;27(9):3511-20
17325036
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5117-22
18362350
J Biol Chem. 2004 May 7;279(19):19948-54
15004018
Exp Mol Med. 2007 Feb 28;39(1):8-13
17334224
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11025-30
12177420
J Cell Biol. 1996 Sep;134(6):1483-97
8830776
Nat Med. 2005 Jun;11(6):672-7
15864313
Cancer Res. 2002 Jan 15;62(2):466-71
11809697
J Cell Physiol. 2002 Apr;191(1):69-81
11920683
Neurosci Lett. 2009 Feb 13;451(1):11-5
19110033
Mol Cell Biol. 1992 Jun;12(6):2484-92
1588952
Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1301-11
16836974
Biochem Soc Trans. 2007 Aug;35(Pt 4):797-801
17635151
Cell Death Differ. 2007 Dec;14(12):2058-67
17885668
Nat Genet. 2003 Dec;35(4):367-71
14625552
Hum Mutat. 2000;15(1):7-12
10612815
Microsc Res Tech. 2000 Feb 1-15;48(3-4):181-91
10679965
Mol Cell. 2004 Mar 12;13(5):627-38
15023334
Science. 2004 Jul 16;305(5682):390-2
15205477
Hum Mol Genet. 1997 May;6(5):747-52
9158149
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):991-6
17215366
J Gene Med. 2008 Feb;10(2):217-24
18074402
Eur J Hum Genet. 2002 Feb;10(2):91-4
11938437
J Cell Biol. 1998 Jul 27;142(2):537-44
9679150
Brain. 2009 Jan;132(Pt 1):147-55
19015158
J Clin Invest. 1998 Aug 15;102(4):844-52
9710454
J Clin Invest. 2004 Dec;114(11):1635-9
15578095
Hum Mol Genet. 2005 Apr 15;14(8):1029-40
15757977
Mol Cell Biol. 2008 Oct;28(20):6384-401
18710944
Science. 1995 Oct 6;270(5233):96-9
7569956
J Cell Biochem. 2003 Aug 15;89(6):1115-25
12898510
Trends Mol Med. 2006 Jun;12(6):279-86
16650805
BMC Cell Biol. 2004 Jan 08;5:1
14711384
Ann Neurol. 2009 Jan;65(1):47-56
19086074
Mol Ther. 2006 Jun;13(6):1149-55
16564230
Biochem Biophys Res Commun. 2000 Nov 2;277(3):639-42
11062006
Nat Med. 2008 Apr;14(4):442-7
18345011
Clin Genet. 2008 Dec;74(6):502-12
18700894
J Biol Chem. 1989 Aug 5;264(22):13122-30
2473986
Neurosci Lett. 2004 Nov 30;372(1-2):17-21
15531080